Clinical Endocrinology · 1977 · 53 citations · 13 references
MedicineEndocrinologyPharmacologyEndocrine PharmacotherapyHormone BiochemistryMineral MetabolismAntithyroid DrugsThyroid DisordersThyroid Hormone BiochemistryPeripheral Drug MetabolismPeripheral Hormone MetabolismPeripheral Thyroid Hormone MetabolismPropranolol TherapySerum Thyroid-stimulating Hormone MeasurementThyroid Disorder PharmacotherapyThyroid Hormone Metabolism AlterationsTriiodothyronine Measurement
Serum triiodothyronine (T3) and thyroxine (T4) levels were measured in twelve hyperthyroid patients before and after treatment with propranolol, 40 mg four times daily, for 2 weeks. There was a significant fall in serum T3 and a significant rise in serum T4 concentrations in the group as a whole and it was concluded that the clinical effectiveness of propranolol in hyperthyroidism may be mediated in part by its action on the peripheral metabolism of thyroid hormones. Propranolol treatment should be withdrawn gradually as removal of the suppressive action of the drug on thyroid hormone metabolism is potentially hazardous, particularly in patients with ischaemic heart disease.
13
INDER J. CHOPRA, Usha Chopra, M. S. Reza et al. · The Journal of Clinical Endocrinology & Metabolism · 1975 · 428 citations
Propranolol-Withdrawal Rebound Phenomenon
Richard R. Miller, Harold G. Olson, Ezra A. Amsterdam et al. · New England Journal of Medicine · 1975 · 408 citations
REDUCED ACTIVE THYROID HORMONE LEVELS IN ACUTE ILLNESS
Albert Burger, Peter M. Suter, Pascal Nicod et al. · The Lancet · 1976 · 176 citations
CONTROLLED TRIAL OF PROPRANOLOL IN THYROTOXICOSIS
R.G. Shanks, Dermot Lowe, D. R. Hadden et al. · The Lancet · 1969 · 151 citations